Eastling Thomas Wilson has filed 11 insider transactions across 1 company since August 2024.
Most recent transaction: a grant/award of 33271 shares of GYRE THERAPEUTICS, INC. ($GYRE) on May 04, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 4, 2026 | GYRE THERAPEUTICS, INC. | $GYRE | Eastling Thomas Wilson | Chief Financial Officer | A | Stock Option (Right to Buy) | 33271 | $0.00 | 125,954.0000 | 103,971,546 | 35.90% | 0.03% |
| May 4, 2026 | GYRE THERAPEUTICS, INC. | $GYRE | Eastling Thomas Wilson | Chief Financial Officer | A | Stock Option (Right to Buy) | 11882 | $0.00 | 45,153.0000 | 103,971,546 | 35.71% | 0.01% |
| May 4, 2026 | GYRE THERAPEUTICS, INC. | $GYRE | Eastling Thomas Wilson | Chief Financial Officer | A | Stock Option (Right to Buy) | 33271 | $0.00 | 66,542.0000 | 103,971,546 | 100.00% | 0.03% |
| May 4, 2026 | GYRE THERAPEUTICS, INC. | $GYRE | Eastling Thomas Wilson | Chief Financial Officer | A | Stock Option (Right to Buy) | 95060 | $0.00 | 128,331.0000 | 103,971,546 | 285.71% | 0.09% |
| May 4, 2026 | GYRE THERAPEUTICS, INC. | $GYRE | Eastling Thomas Wilson | Chief Financial Officer | A | Stock Option (Right to Buy) | 92683 | $0.00 | 125,954.0000 | 103,971,546 | 278.57% | 0.09% |
| May 4, 2026 | GYRE THERAPEUTICS, INC. | $GYRE | Eastling Thomas Wilson | Chief Financial Officer | A | Stock Option (Right to Buy) | 95060 | $0.00 | 128,331.0000 | 103,971,546 | 285.71% | 0.09% |
| May 4, 2026 | GYRE THERAPEUTICS, INC. | $GYRE | Eastling Thomas Wilson | Chief Financial Officer | A | Stock Option (Right to Buy) | 47530 | $0.00 | 80,801.0000 | 103,971,546 | 142.86% | 0.05% |
| June 4, 2025 | GYRE THERAPEUTICS, INC. | $GYRE | Eastling Thomas Wilson | Not found | A | Stock Option (Right to Buy) | 26000 | $0.00 | 26,000.0000 | 102,293,526 | 9999.99% | 0.03% |
| April 16, 2025 | GYRE THERAPEUTICS, INC. | $GYRE | Eastling Thomas Wilson | Not found | M | Common Stock | 15000 | $6.93 | 15,000.0000 | 102,293,526 | 9999.99% | 0.01% |
| April 16, 2025 | GYRE THERAPEUTICS, INC. | $GYRE | Eastling Thomas Wilson | Not found | M | Stock Option (Right to Buy) | 15000 | $0.00 | 299,652.0000 | 102,293,526 | 4.77% | 0.01% |
| Aug. 14, 2024 | GYRE THERAPEUTICS, INC. | $GYRE | Eastling Thomas Wilson | Not found | A | Stock Option (Right to Buy) | 26000 | $0.00 | 26,000.0000 | 65,831,675 | 9999.99% | 0.04% |